Koyfin Home > Directory > Health Care > Amgen Inc > Other Liabilities

Amgen Inc Other Liabilities Chart (AMGN)

Amgen Inc annual/quarterly Other Liabilities from 2010 to 2020.
  • Amgen Inc Other Liabilities for the quarter ending September 09, 2020 was $9,529m a -3.48% decrease of -332m year over year
  • Amgen Inc Other Liabilities for the last 12 months ending September 09, 2020 was $9,529m a -3.48% decrease of -332m year over year
  • Amgen Inc Annual Other Liabilities for 2019 was $9,861m a -10.72% decrease of -1,057m from 2018
  • Amgen Inc Annual Other Liabilities for 2018 was $10,918m a -5.36% decrease of -585m from 2017
  • Amgen Inc Annual Other Liabilities for 2017 was $11,503m a 44.76% increase of 5,149m from 2016
Other Balance Sheet Metrics:
  • Amgen Inc Total Assets for the quarter ending December 12, 2018 was $66,416m a -7.15% decrease of -4,748m year over year
  • Amgen Inc Total Equity for the quarter ending December 12, 2018 was $12,500m a -24.96% decrease of -3,120m year over year
View Chart On Koyfin

Quarterly AMGN Other Liabilities Data

09/2020$9,529m
06/2020$9,696m
03/2020$10,349m
12/2019$9,861m
09/2019$9,778m
06/2019$9,796m
03/2019$10,772m
12/2018$10,918m
09/2018$11,202m
06/2018$11,361m

Annual AMGN Other Liabilities Data

2019$9,861m
2018$10,918m
2017$11,503m
2016$6,354m
2015$5,520m
2014$6,008m
2013$6,459m
2012$3,013m
2011$2,744m
2010$2,098m